Health Canada has given its stamp of approval to Pfizer-BioNTech’s new COVID-19 vaccine that targets the Omicron XBB.1.5 subvariant.
| |
| |
|
| | | | Subscribe to our other newsletters | | | | A curated newsletter on the day’s most important news. | The biggest headlines to start your morning. | A twice-weekly update on the latest from Parliament Hill. |
| | |
|
